ARVN CIK: 1655759

Arvinas, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.55
FY22:
1.24
FY23:
1.28
FY24:
1.07
FY25:
0.70
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.03
FY23:
0.02
FY24:
0.02
FY25:
0.02
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.58
FY22:
1.27
FY23:
1.30
FY24:
1.09
FY25:
0.72

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.26
FY22:
0.30
FY23:
0.26
FY24:
0.23
FY25:
0.14
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.54
FY22:
0.41
FY23:
0.39
FY24:
0.30
FY25:
0.14
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.56
FY23:
0.66
FY24:
0.56
FY25:
0.43
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.58
FY22:
1.27
FY23:
1.30
FY24:
1.09
FY25:
0.72

All amounts in billions USD Data source:SEC EDGAR